These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 24861641)

  • 1. A summary of the 20th International Symposium on Hepatitis C Virus and Related Viruses.
    Beard MR; Ffrench R; Gowans EJ; Helbig KJ; Eyre NM; Douglas MM; Grebely J; Ahlenstiel G; Locarnini S; George J; Shackel NA; White PA; Thompson AJ; Drummer HE
    Gastroenterology; 2014 Jul; 147(1):e1-4. PubMed ID: 24861641
    [No Abstract]   [Full Text] [Related]  

  • 2. The Beginning of Ending Hepatitis C Virus: A Summary of the 26th International Symposium on Hepatitis C Virus and Related Viruses.
    Shin EC; Han JW; Kang W; Kato T; Kim SJ; Zhong J; Kim S; Park SH; Sung PS; Watashi K; Park JY; Windisch MP; Oh JW; Wakita T; Han KH; Jang SK
    Viruses; 2020 Mar; 12(3):. PubMed ID: 32168867
    [No Abstract]   [Full Text] [Related]  

  • 3. Experimental models for hepatitis C viral infection.
    Boonstra A; van der Laan LJ; Vanwolleghem T; Janssen HL
    Hepatology; 2009 Nov; 50(5):1646-55. PubMed ID: 19670425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Addressing the next challenges: A summary of the 22nd international symposium on hepatitis C virus and related viruses.
    Baumert TF; Schuster C; Cosset FL; Dubuisson J; Hofmann M; Tautz N; Zeisel MB; Thimme R
    J Hepatol; 2016 Apr; 64(4):968-73. PubMed ID: 26780288
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Innate and adaptive immune responses in HCV infections.
    Heim MH; Thimme R
    J Hepatol; 2014 Nov; 61(1 Suppl):S14-25. PubMed ID: 25443342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A summary of the 18th International Symposium on Hepatitis C Virus and Related Viruses.
    Polyak SJ; Morishima C; Scott JD; Gastaminza P; Cox A; de Araújo ES; Higgs MR; Loo YM; Golden-Mason L; Lindenbach BD; Baumert TF; Randall G; Gale M
    Gastroenterology; 2012 Jan; 142(1):e1-5. PubMed ID: 22185796
    [No Abstract]   [Full Text] [Related]  

  • 7. Innate and Adaptive Immune Responses in Chronic HCV Infection.
    Dustin LB
    Curr Drug Targets; 2017; 18(7):826-843. PubMed ID: 26302811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immune and non-immune responses to hepatitis C virus infection.
    Sun J; Rajsbaum R; Yi M
    World J Gastroenterol; 2015 Oct; 21(38):10739-48. PubMed ID: 26478666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infectious diseases. Hard-won advances spark excitement about hepatitis C.
    Crabb C
    Science; 2001 Oct; 294(5542):506-7. PubMed ID: 11641482
    [No Abstract]   [Full Text] [Related]  

  • 10. Overcoming the roadblocks in hepatitis C virus infection.
    Baumert TF; Zeuzem S
    J Hepatol; 2014 Nov; 61(1 Suppl):S1-2. PubMed ID: 25443338
    [No Abstract]   [Full Text] [Related]  

  • 11. The accelerating pace of HCV research: a summary of the 15th International Symposium on Hepatitis C Virus And Related Viruses.
    Lanford RE; Evans MJ; Lohmann V; Lindenbach B; Gale M; Rehermann B; Chang KM; Lemon SM
    Gastroenterology; 2009 Jan; 136(1):9-16. PubMed ID: 19026648
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis C virus triggers apoptosis of a newly developed hepatoma cell line through antiviral defense system.
    Zhu H; Dong H; Eksioglu E; Hemming A; Cao M; Crawford JM; Nelson DR; Liu C
    Gastroenterology; 2007 Nov; 133(5):1649-59. PubMed ID: 17983809
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New targets for treatment against HCV infection.
    Pan Q; van der Laan LJ
    Best Pract Res Clin Gastroenterol; 2012 Aug; 26(4):505-15. PubMed ID: 23199508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Hepatitis C virus-host interaction involved in viral replication: toward the identification of antiviral targets.
    Suzuki T
    Jpn J Infect Dis; 2010 Sep; 63(5):307-11. PubMed ID: 20858994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis C virus: current concepts and future challenges.
    Klenerman P; Gupta PK
    QJM; 2012 Jan; 105(1):29-32. PubMed ID: 22123990
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiviral therapy in liver transplant recipients: is SVR the only endpoint that matters?
    Kuo A; Terrault NA
    J Hepatol; 2007 Mar; 46(3):359-61. PubMed ID: 17223220
    [No Abstract]   [Full Text] [Related]  

  • 17. HCV research and anti-HCV drug discovery: toward the next generation.
    Wakita T
    Adv Drug Deliv Rev; 2007 Oct; 59(12):1196-9. PubMed ID: 17905463
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stealth and cunning: hepatitis B and hepatitis C viruses.
    Wieland SF; Chisari FV
    J Virol; 2005 Aug; 79(15):9369-80. PubMed ID: 16014900
    [No Abstract]   [Full Text] [Related]  

  • 19. New insights into hepatitis B and C virus co-infection.
    Brass V; Moradpour D
    J Hepatol; 2009 Sep; 51(3):423-5. PubMed ID: 19596479
    [No Abstract]   [Full Text] [Related]  

  • 20. How does interferon inhibit HCV cell entry?
    Jones M; Owen JS
    Gut; 2008 May; 57(5):573-4. PubMed ID: 18408099
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.